Published in Appl Environ Microbiol on November 01, 1999
Combined effects of blood and temperature shift on Borrelia burgdorferi gene expression as determined by whole genome DNA array. Infect Immun (2004) 2.35
Genome sequence of the pathogenic intestinal spirochete brachyspira hyodysenteriae reveals adaptations to its lifestyle in the porcine large intestine. PLoS One (2009) 1.41
Carbadox has both temporary and lasting effects on the swine gut microbiota. Front Microbiol (2014) 0.91
Brachyspira (Serpulina) hyodysenteriae gyrB mutants and interstrain transfer of coumermycin A(1) resistance. Appl Environ Microbiol (2001) 0.88
The coenzyme A disulphide reductase of Borrelia burgdorferi is important for rapid growth throughout the enzootic cycle and essential for infection of the mammalian host. Mol Microbiol (2011) 0.86
Differential regulation of the multiple flagellins in spirochetes. J Bacteriol (2010) 0.82
Complete genome sequence and description of Salinispira pacifica gen. nov., sp. nov., a novel spirochaete isolated form a hypersaline microbial mat. Stand Genomic Sci (2015) 0.82
Cloning and DNA sequence analysis of an immunogenic glucose-galactose MglB lipoprotein homologue from Brachyspira pilosicoli, the agent of colonic spirochetosis. Infect Immun (2000) 0.80
Adherence of Brachyspira hyodysenteriae to porcine intestinal epithelial cells is inhibited by antibodies against outer membrane proteins. Curr Microbiol (2012) 0.78
The Exposed Proteomes of Brachyspira hyodysenteriae and B. pilosicoli. Front Microbiol (2016) 0.75
Oxygen and the growth and metabolism of Clostridium acetobutylicum. J Gen Microbiol (1971) 4.91
Selective medium for isolation of Treponema hyodysenteriae. J Clin Microbiol (1976) 2.85
Serpulina pilosicoli sp. nov., the agent of porcine intestinal spirochetosis. Int J Syst Bacteriol (1996) 2.14
Localization of spirochetes with the structural characteristics of Treponema hyodysenteriae in the lesions of swine dysentery. Infect Immun (1974) 1.85
The comparative metabolism of the mollicutes (Mycoplasmas): the utility for taxonomic classification and the relationship of putative gene annotation and phylogeny to enzymatic function in the smallest free-living cells. Crit Rev Microbiol (1997) 1.80
Oxygen utilization by Lactobacillus plantarum. I. Oxygen consuming reactions. Arch Microbiol (1980) 1.71
Identification of two distinct NADH oxidases corresponding to H2O2-forming oxidase and H2O-forming oxidase induced in Streptococcus mutans. J Gen Microbiol (1993) 1.61
Oxidation of reduced diphosphopyridine nucleotide by Clostridium perfringens. I. Relation of peroxide to the overall reaction. J Bacteriol (1959) 1.47
Erythrocytes as a source of essential lipids for Treponema hyodysenteriae. Infect Immun (1987) 1.43
Inactivation of Serpulina hyodysenteriae flaA1 and flaB1 periplasmic flagellar genes by electroporation-mediated allelic exchange. J Bacteriol (1995) 1.42
Isolation and properties of an H2O-forming NADH oxidase from Streptococcus faecalis. Eur J Biochem (1986) 1.40
The effect of oxygen on the growth and mannitol fermentation of Streptococcus mutants. J Gen Microbiol (1984) 1.29
Lactose metabolism by Staphylococcus aureus: characterization of lacABCD, the structural genes of the tagatose 6-phosphate pathway. J Bacteriol (1991) 1.28
Inactivation of a Serpula (Treponema) hyodysenteriae hemolysin gene by homologous recombination: importance of this hemolysin in pathogenesis in mice. FEMS Microbiol Lett (1992) 1.27
Molecular cloning and analysis of the gene encoding the NADH oxidase from Streptococcus faecalis 10C1. Comparison with NADH peroxidase and the flavoprotein disulfide reductases. J Mol Biol (1992) 1.25
Purification and characterization of NADH oxidase from Serpulina (Treponema) hyodysenteriae. J Bacteriol (1993) 1.23
Correlation of oxygen utilization and hydrogen peroxide accumulation with oxygen induced enzymes in Lactobacillus plantarum cultures. Arch Microbiol (1984) 1.20
Treponema hyodysenteriae growth under various culture conditions. Vet Microbiol (1988) 1.18
Chemotactic response to mucin by Serpulina hyodysenteriae and other porcine spirochetes: potential role in intestinal colonization. Infect Immun (1994) 1.17
Dual flaA1 flaB1 mutant of Serpulina hyodysenteriae expressing periplasmic flagella is severely attenuated in a murine model of swine dysentery. Infect Immun (1996) 1.16
Purification and characterization of NADH oxidase from a strain of Leuconostoc mesenteroides. J Biochem (1985) 1.12
Reduced virulence of Serpulina hyodysenteriae hemolysin-negative mutants in pigs and their potential to protect pigs against challenge with a virulent strain. Infect Immun (1994) 1.09
A H2O-producing NADH oxidase from the protozoan parasite Giardia duodenalis. Eur J Biochem (1996) 1.07
Glucose metabolism and NADH recycling by Treponema hyodysenteriae, the agent of swine dysentery. Appl Environ Microbiol (1989) 1.03
Anaerobes response to oxygen: the sulfate-reducing bacteria. Anaerobe (1996) 1.02
Motility and chemotaxis in Serpulina hyodysenteriae. Vet Microbiol (1996) 1.02
Oxygen scavenging, NADH oxidase and metronidazole resistance in Helicobacter pylori. J Antimicrob Chemother (1997) 0.98
A thermostable NADH oxidase from anaerobic extreme thermophiles. Biochem J (1992) 0.94
Reduced nicotinamide adenine dinucleotide oxidase involvement in defense against oxygen toxicity of Streptococcus mutans. Oral Microbiol Immunol (1992) 0.91
Oxygen activation and defence against oxygen toxicity in a psychrophilic Bacteroidaceae. Arch Microbiol (1989) 0.86
Purification and characterization of NADH oxidase from the archaea Sulfolobus acidocaldarius and Sulfolobus solfataricus. Biotechnol Appl Biochem (1996) 0.84
The NADH oxidase from the thermoacidophilic archaea Acidianus ambivalens: isolation and physicochemical characterisation. Biochem Biophys Res Commun (1998) 0.83
High-affinity oxygen uptake by Bifidobacterium bifidum. Antonie Van Leeuwenhoek (1992) 0.81
Pathological observation on experimental swine dysentery. Natl Inst Anim Health Q (Tokyo) (1979) 0.80
Monitoring experimental swine dysentery: rectal swab blood test and Serpulina (Treponema) hyodysenteriae detection. Vet Microbiol (1993) 0.77
Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile. J Clin Microbiol (1982) 4.35
The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype. Clin Pharmacol Ther (2007) 4.33
Identification of elements involved in transcriptional regulation of the Escherichia coli cad operon by external pH. J Bacteriol (1992) 2.61
Escherichia coli O157:H7 requires intimin for enteropathogenicity in calves. Infect Immun (1998) 2.37
Pathogenicity of Escherichia coli O157:H7 in the intestines of neonatal calves. Infect Immun (1997) 2.35
Serpulina pilosicoli sp. nov., the agent of porcine intestinal spirochetosis. Int J Syst Bacteriol (1996) 2.14
Ecology of Candida albicans gut colonization: inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism. Infect Immun (1985) 2.03
High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. J Clin Oncol (1997) 1.75
Reclassification of Treponema hyodysenteriae and Treponema innocens in a new genus, Serpula gen. nov., as Serpula hyodysenteriae comb. nov. and Serpula innocens comb. nov. Int J Syst Bacteriol (1991) 1.55
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer. JAMA (1999) 1.49
Purification and characterization of VSH-1, a generalized transducing bacteriophage of Serpulina hyodysenteriae. J Bacteriol (1997) 1.46
Multiplex PCR for enterotoxigenic, attaching and effacing, and Shiga toxin-producing Escherichia coli strains from calves. J Clin Microbiol (1998) 1.44
High-dose chemotherapy of breast cancer: is the question answered? J Clin Oncol (1995) 1.43
Effect of various antibiotics on gastrointestinal colonization and dissemination by Candida albicans. Sabouraudia (1985) 1.43
Inactivation of Serpulina hyodysenteriae flaA1 and flaB1 periplasmic flagellar genes by electroporation-mediated allelic exchange. J Bacteriol (1995) 1.42
Identification of Pasteurella multocida virulence genes in a septicemic mouse model using signature-tagged mutagenesis. Microb Pathog (2000) 1.42
Identification and characterization of Serpulina pilosicoli isolates recovered from the blood of critically ill patients. J Clin Microbiol (1997) 1.38
Adhesion and association mechanisms of Candida albicans. Curr Top Med Mycol (1988) 1.24
Purification and characterization of NADH oxidase from Serpulina (Treponema) hyodysenteriae. J Bacteriol (1993) 1.23
Pathogenesis of Escherichia coli O157:H7 in weaned calves. Adv Exp Med Biol (1999) 1.21
Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer. Clin Oncol (R Coll Radiol) (2010) 1.17
Fatigue, pain, and depression in pre-autotransplant breast cancer patients. Cancer Pract (2000) 1.16
Dual flaA1 flaB1 mutant of Serpulina hyodysenteriae expressing periplasmic flagella is severely attenuated in a murine model of swine dysentery. Infect Immun (1996) 1.16
Differentiation of Serpulina species by NADH oxidase gene (nox) sequence comparisons and nox-based polymerase chain reaction tests. Vet Microbiol (1999) 1.15
Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapy. Eur J Surg Oncol (2005) 1.13
Characterization of porcine intestinal receptors for the K88ac fimbrial adhesin of Escherichia coli as mucin-type sialoglycoproteins. Infect Immun (1994) 1.11
The effectiveness of the comprehensive coping strategy program on clinical outcomes in breast cancer autologous bone marrow transplantation. Cancer Nurs (2000) 1.11
Effect of dietary stress on fecal shedding of Escherichia coli O157:H7 in calves. Appl Environ Microbiol (1998) 1.08
The spirochete FlaA periplasmic flagellar sheath protein impacts flagellar helicity. J Bacteriol (2000) 1.05
Identification of Actinobacillus pleuropneumoniae virulence genes using signature-tagged mutagenesis in a swine infection model. Microb Pathog (2000) 1.04
Evaluation of ivermectin on performance of beef cattle on pasture in alberta. Can Vet J (1988) 1.02
Mitomycin C induction of bacteriophages from Serpulina hyodysenteriae and Serpulina innocens. FEMS Microbiol Lett (1995) 1.00
Phenotypic characteristics of Serpulina pilosicoli the agent of intestinal spirochaetosis. FEMS Microbiol Lett (1996) 0.99
Shiga toxin-producing Escherichia coli infection: temporal and quantitative relationships among colonization, toxin production, and systemic disease. J Infect Dis (2000) 0.99
Multiple lymphomatous polyposis of the gastrointestinal tract. A clinicopathologically distinctive form of non-Hodgkin's lymphoma of B-cell centrocytic type. Am J Surg Pathol (1989) 0.99
Angiostrongylosis with disseminated larval infection associated with signs of ocular and nervous disease in an imported dog. Can Vet J (1991) 0.98
Molecular characterization of Serpulina (Treponema) hyodysenteriae isolates representing serotypes 8 and 9. J Clin Microbiol (1992) 0.98
Sequence of the bovine CD18-encoding cDNA: comparison with the human and murine glycoproteins. Gene (1992) 0.97
Prevalences of some virulence genes among Escherichia coli isolates from swine presented to a diagnostic laboratory in Iowa. J Vet Diagn Invest (1999) 0.97
Characterization of the gene encoding Mhp1 from Mycoplasma hyopneumoniae and examination of Mhp1's vaccine potential. Vaccine (1997) 0.95
Staphylococcal exotoxins stimulate nitric oxide-dependent murine macrophage tumoricidal activity. Infect Immun (1991) 0.95
Feasibility and efficacy of a supervised exercise intervention in de-conditioned cancer survivors during the early survivorship phase: the PEACH trial. J Cancer Surviv (2013) 0.94
Lachnospira pectinoschiza sp. nov., an anaerobic pectinophile from the pig intestine. Int J Syst Bacteriol (1994) 0.94
Detection of tumor cells in the bone marrow, peripheral blood, and apheresis products of breast cancer patients using flow cytometry. Exp Hematol (1995) 0.93
Restriction of antigen recognition in mouse B lymphocytes by genes mapping within the major histocompatibility complex. J Immunol (1980) 0.92
Differentiation of intestinal spirochaetes by multilocus enzyme electrophoresis analysis and 16S rRNA sequence comparisons. FEMS Microbiol Lett (1996) 0.92
Characterization of flaA- and flaB- mutants of Serpulina hyodysenteriae: both flagellin subunits, FlaA and FlaB, are necessary for full motility and intestinal colonization. FEMS Microbiol Lett (1997) 0.92
Expression of heat-stable enterotoxin STb by adherent Escherichia coli is not sufficient to cause severe diarrhea in neonatal pigs. Infect Immun (1998) 0.91
Dissemination of yeasts after gastrointestinal inoculation in antibiotic-treated mice. Sabouraudia (1983) 0.91
Spontaneous regression of metastatic Merkel cell carcinoma. Ir Med J (2010) 0.91
Cyclophosphamide and 4-Hydroxycyclophosphamide/aldophosphamide kinetics in patients receiving high-dose cyclophosphamide chemotherapy. Clin Cancer Res (1996) 0.91
Intervention with Shiga toxin (Stx) antibody after infection by Stx-producing Escherichia coli. J Infect Dis (2000) 0.91
Nonlinear pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide/aldophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation. Drug Metab Dispos (1997) 0.91
Impact of age on outcome of patients with cancer undergoing autologous bone marrow transplant. J Clin Oncol (1996) 0.90
Bacteroides pectinophilus sp. nov. and Bacteroides galacturonicus sp. nov.: two pectinolytic bacteria from the human intestinal tract. Appl Environ Microbiol (1986) 0.90
Regulation of Candida albicans populations in the gastrointestinal tract: mechanisms and significance in GI and systemic candidiasis. Curr Top Med Mycol (1989) 0.90
Denitrobacterium detoxificans gen. nov., sp. nov., a ruminal bacterium that respires on nitrocompounds. Int J Syst Evol Microbiol (2000) 0.90
Specificity of effector T lymphocytes in autologous graft-versus-host disease: role of the major histocompatibility complex class II invariant chain peptide. Blood (1997) 0.89
Antibiotic selective markers and spirochete genetics. J Mol Microbiol Biotechnol (2000) 0.89
Serpulina alvinipulli sp. nov., a new Serpulina species that is enteropathogenic for chickens. Int J Syst Bacteriol (1998) 0.89
Nutritionally limited pectinolytic bacteria from the human intestine. Appl Environ Microbiol (1985) 0.89
The excessive cost of baseline diagnostic imaging in early breast cancer. Ir Med J (2009) 0.88
Testing the 'teachable moment' premise: does physical activity increase in the early survivorship phase? Support Care Cancer (2013) 0.88
Intake and blood levels of fatty acids in treated patients with phenylketonuria. J Pediatr Gastroenterol Nutr (2001) 0.88
Activities of an employer independent Occupational Medicine Clinic, Cook County Hospital, 1979-1981. Am J Public Health (1982) 0.88
Effect of ivermectin on weight gains on yearling steers on pasture in central Alberta. Can Vet J (1989) 0.88
Inhibition of Candida albicans by the anaerobic oral flora of mice in vitro. Sabouraudia (1981) 0.87
Biochemical analysis of phototransduction and visual cycle in zebrafish larvae. Methods Enzymol (2000) 0.87
Exogenous C1q reconstitutes resident but not inflammatory mouse peritoneal macrophages for Fc receptor-dependent cellular cytotoxicity and phagocytosis. Relationship to endogenous C1q availability. J Immunol (1989) 0.87
Cecal spirochetosis in commercial laying hens. Avian Dis (1995) 0.87
First report of Ollulanus tricuspis (Nematoda) from western Canada. J Parasitol (1984) 0.86
Identification of a new intestinal spirochete with pathogenicity for chickens. Infect Immun (1995) 0.86
Benzimidazole resistance in horses in western Canada. Can Vet J (1989) 0.86
Recent advances in systemic therapy for breast cancer. Curr Opin Oncol (1998) 0.85
Optimally tolerated dose of lapatinib in combination with docetaxel plus trastuzumab in first-line treatment of HER2-positive metastatic breast cancer. Ann Oncol (2013) 0.85
The effect of aerobic exercise on metabolic and inflammatory markers in breast cancer survivors--a pilot study. Support Care Cancer (2013) 0.85
Effects of valproic acid on organic acid metabolism in children: a metabolic profiling study. Clin Pharmacol Ther (2011) 0.85
An outbreak of multiply resistant Serratia marcescens: the importance of persistent carriage. Bone Marrow Transplant (2000) 0.85
Galactose breath testing distinguishes variant and severe galactose-1-phosphate uridyltransferase genotypes. Pediatr Res (2000) 0.84
Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation. Cancer Res (1995) 0.83
Vascular ultrastructure and DNA fragmentation in swine infected with Shiga toxin-producing Escherichia coli. Vet Pathol (2000) 0.83
Unique Immunogenic Proteins in Heterodera glycines Eggshells. J Nematol (1997) 0.83
Pathogenesis of O157:H7 Escherichia coli infection in neonatal calves. Adv Exp Med Biol (1997) 0.83
Similar breast cancer cell contamination of single-day peripheral-blood progenitor-cell collections obtained after priming with hematopoietic growth factor alone or after cyclophosphamide followed by growth factor. J Clin Oncol (1996) 0.82
Micronema deletrix in the kidney of a horse. Can Vet J (1990) 0.82
Development of the nematode eyeworm, Thelazia skrjabini (Nematoda: Thelazioidea), in experimentally infected face flies, Musca autumnalis (Diptera: Muscidae). J Parasitol (1991) 0.82
Perioperative diagnosis of the positive axilla in breast cancer: a safe, time efficient algorithm. Eur J Surg Oncol (2011) 0.81
Edema disease as a model for systemic disease induced by Shiga toxin-producing E. coli. Adv Exp Med Biol (1999) 0.81
A survey of ectoparasites on cattle in central alberta, november 1984-july 1985. Can Vet J (1986) 0.81
P53 abnormalities and outcomes in colorectal cancer: a systematic review. Br J Cancer (2005) 0.81
Pain, psychological distress, health status, and coping in patients with breast cancer scheduled for autotransplantation. Oncol Nurs Forum (1999) 0.81
Identification and characterization of CYP2D6*56B, an allele associated with the poor metabolizer phenotype. Clin Pharmacol Ther (2007) 0.81
Redox potential measurements of the Mycobacterium tuberculosis heme protein KatG and the isoniazid-resistant enzyme KatG(S315T): insights into isoniazid activation. Biochemistry (2000) 0.81
Phase I trial of the matrix metalloproteinase inhibitor BAY12-9566 in patients with advanced solid tumors. Cancer Chemother Pharmacol (2001) 0.80
Vinorelbine and the topoisomerase 1 inhibitors: current and potential roles in breast cancer chemotherapy. Breast Cancer Res Treat (1995) 0.80
Effect of ivermectin on weight gain of calves on pasture in Alberta. Can Vet J (1990) 0.80
Self-recognition ability in mentally retarded adolescents. J Psychol (1981) 0.80
Strategies for fertility preservation after chemotherapy: awareness among Irish cancer specialists. Ir Med J (2011) 0.79
The cost of the inpatient management of febrile neutropenia in cancer patients--a micro-costing study in the Irish healthcare setting. Eur J Cancer Care (Engl) (2014) 0.78